There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Ironwood Pharma (NASDAQ: IRWD) and Allena Pharmaceuticals Inc (NASDAQ: ALNA) with bullish sentiments.
Ironwood Pharma (NASDAQ: IRWD)
In a report released today, Boris Peaker from Cowen & Co. maintained a Buy rating on Ironwood Pharma (NASDAQ: IRWD), with a price target of $20. The company’s shares opened today at $18.69.
According to TipRanks.com, Peaker is a 5-star analyst with an average return of 17.9% and a 51.9% success rate. Peaker covers the Healthcare sector, focusing on stocks such as Corvus Pharmaceuticals Inc, Stemline Therapeutics Inc, and Mersana Therapeutics Inc.
Currently, the analyst consensus on Ironwood Pharma is Strong Buy and the average price target is $19.75, representing a 5.7% upside.
In a report issued on April 19, Berenberg Bank also initiated coverage with a Buy rating on the stock with a $25 price target.
Find more picks by Best Performing Analysts >>
Allena Pharmaceuticals Inc (NASDAQ: ALNA)
Cowen & Co. analyst Ritu Baral maintained a Buy rating on Allena Pharmaceuticals Inc (NASDAQ: ALNA) today. The company’s shares opened today at $15.09.
According to TipRanks.com, Baral is a top 100 analyst with an average return of 31.7% and a 53.7% success rate. Baral covers the Healthcare sector, focusing on stocks such as Madrigal Pharmaceuticals Inc, ACADIA Pharmaceuticals Inc, and Global Blood Therapeutics.
Currently, the analyst consensus on Allena Pharmaceuticals Inc is Strong Buy and the average price target is $40.50, representing a 168.4% upside.
In a report issued on April 24, B.Riley FBR also initiated coverage with a Buy rating on the stock with a $23.50 price target.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
